The Clinical Syndrome of Striatal Dopamine Deficiency

Parkinsonism

1967 • 11,463 citations

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

1983 • 4,822 citations

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

1983 • 2,149 citations

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1979 • 1,356 citations

Aging and Extrapyramidal Function

1977 • 650 citations

Is the mesocortical dopaminergic system involved in Parkinson disease?

1980 • 412 citations

Parkinsonism Induced By 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP): Implications for Treatment and the Pathogenesis of Parkinson’s Disease

1984 • 277 citations

Relation Between Plasma and Cerebrospinal Fluid Levels of 3-Methoxy-4-Hydroxyphenylglycol

1983 • 203 citations

Brain neurotransmitter changes in Parkinson's disease

1981 • 157 citations

Neurochemistry of Parkinson's disease: relation between striatal and limbic dopamine.

1978 • 130 citations

Pathology of Parkinson's disease

1981 • 121 citations

Simultaneous measurement of plasma 4-hydroxy-3-methoxyphenylethlene glycol and 3,4-dihydroxyphenylethylene glycol by gas chromatography mass spectrometry

1981 • 68 citations

Urinary Catecholamine Metabolites Distinguish Different Types of Sympathetic Neuronal Dysfunction in Patients with Orthostatic Hypotension

1983 • 52 citations

Parkinson’s Disease: Biochemistry, Clinical Pathology, and Treatment

1983 • 26 citations